nivolumab

nivolumab
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 2015-08-27 00:00:00
Sponsor Bristol-Myers Squibb Co;P. O. Box 4000;Princeton, New Jersey, 08543
Related Access Program
Center Trials & Treatment – Glioblastoma by Gene Expression Profile Center Trials & Treatment – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Celldex Therapeutics – Recurrent GBM